Zentalis Pharmaceuticals
ZNTL
#9381
Rank
NZ$0.24 B
Marketcap
NZ$2.49
Share price
0.00%
Change (1 day)
4.18%
Change (1 year)

EPS for Zentalis Pharmaceuticals (ZNTL)

EPS in 2026 (TTM): NZ-$3.15

According to Zentalis Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$3.35. In 2021 the company made an earnings per share (EPS) of NZ-$6.91 a decrease over its 2020 EPS that were of NZ-$5.83.

EPS history for Zentalis Pharmaceuticals from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$3.15
2021NZ-$6.9118.48%
2020NZ-$5.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
NZ-$0.35-89.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ-$1.74-48.09%๐Ÿ‡บ๐Ÿ‡ธ USA